CTIC Financial Facts
Selling, general and administrative: 15.22MNet loss attributable to CTI: -29.18M
See Full Income Statement
Commitments and contingencies: 0
Prepaid expenses and other current assets: 1.77M
See Full Balance Sheet
Cell Therapeutics, Inc. (CTIC) Earnings
|
Expand Research on CTIC
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -28.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/3/23 | Q223 | N/A | -$0.08 | N/A | N/A | $28.8M | N/A | N/A | N/A | ||
| 5/4/23 | Q123 | N/A | -$0.11 | N/A | N/A | $22.95M | N/A | N/A | N/A | ||
5/11/23  |
Q123 | N/A | -$0.11 | N/A | N/A | $22.95M | N/A | N/A | N/A | ||
| 3/6/23 | Q422 | N/A | -$0.10 | N/A | N/A | $23.67M | N/A | N/A | N/A | ||
| 11/7/22 | Q322 | -$0.26 | -$0.14 | -$0.12 | N/A | $17.8M | N/A |  | | Details | |
| 8/8/22 | Q222 | -$0.21 | -$0.19 | -$0.02 | $12.3M | $9.1M | N/A | | | Details | |
| 5/12/22 |  |
Q122 | -$0.37 | -$0.33 | -$0.04 | $2.3M | $13M | N/A | | | Details |
| 8/5/21 |
|
Q221 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A |
